Happy Lunar New Year from the USC US-China Institute!
Trojan Talk with Fosun Pharma
Talent acquisition team of Fosun Pharma and its subsidiary Henlix will come to the campus and introduce the company, the culture, job opportunities and hiring process to USC students.
When:
September 12, 2018 2:00pm to 3:00pm
Where
Student Registration link: http://uscshanghai.mikecrm.com/V7H8aHR
(Registration deadline: September 12th, 8am)
Are you passionate about innovation for good health? Would you like to know more about working in the leading healthcare group in China? Come and join our presentation at 2pm on Sep. 12th, at Cardinal and Gold Conference Room.
Talent acquisition team of Fosun Pharma and its subsidiary Henlix will come to the campus and introduce the company, the culture, job opportunities and hiring process to you. We will also have a guest speaker, Dr.Xu, Vice President of Research, at Henlix, will be the guest speaker to share his experience and insights.
JOB OPENINGS:
Finance Management Trainee
Digital Technology Management Trainee- Innovation Program
Digital Technology Management Trainee- Software engineering track
Securities affairs representative
About Fosun Pharma
Established in 1994, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ( “Fosun Pharma” ; stock code: 600196.SH, 02196.HK) is a leading healthcare group in the PRC. With the mission of persistently improving human health, Fosun Pharma’ s business covers all key sectors of healthcare industry chain including pharmaceutical manufacturing and R&D, healthcare services, medical diagnosis and devices, as well as pharmaceutical distribution and retail.
Fosun Pharma maintains a national recognized enterprise technology center and a highly capable international R&D team, with relentless e_orts exerted on innovation and research of therapeutic areas including cardiovascular system, central nervous system, blood system, metabolism and alimentary system, anti-infection and oncology. Looking forward, Fosun Pharma will adhere to the brand philosophy of “Innovation for Good Health” , and will continue sticking to the development strategy of “organic growth, external expansion and integrated development” , striving to become a top-tier enterprise in the global mainstream pharmaceutical and healthcare market.
Cost:
Free
Event Website URL:
Featured Articles
January 4, 2024
We note the passing of many prominent individuals who played some role in U.S.-China affairs, whether in politics, economics or in helping people in one place understand the other.
Events
Thursday, March 21, 2024 - 4:00pm PST
Ying Zhu looks at new developments for Chinese and global streaming services.
Tuesday, March 19, 2024 - 4:00pm
David Zweig examines China's talent recruitment efforts, particularly towards those scientists and engineers who left China for further study. U.S. universities, labs and companies have long brought in talent from China. Are such people still welcome?